Low dose, alternating electric current inhibits growth of prostate cancer
January 21st, 2010 Posted in prostate cancerA group of researchers at the University of Washington working with LaZure Scientific have tested a new low-dose alternating electric current (LDAEC) device for the treatment of prostate tumors. All the work was performed in xenograft models.
In the online edition of Prostate, researchers concluded that low dose, alternating electric current inhibits growth of prostate cancer.